Other
cetylpyridinium chloride
cetylpyridinium chloride is an intervention with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
1
20%
Ph phase_2
1
20%
Ph phase_3
2
40%
Ph not_applicable
1
20%
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Early Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 32 (40.0%)
N/A1 (20.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Effect of Mouthwashes on Oral Wound Healing and Microbiome
NCT05270382
completedearly_phase_1
Preventive Effects of Cetylpyridinium Chloride on SarcopeniaStudy
NCT02297997
completedphase_2
Feasibility and Acceptability of Use of Daily Oral Rinse in Pregnant Women in Rural Nepal
NCT02788786
completedphase_3
Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.
NCT00729599
completedphase_3
Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power
NCT00687037
Clinical Trials (5)
Showing 5 of 5 trials
NCT05270382Not Applicable
Effect of Mouthwashes on Oral Wound Healing and Microbiome
NCT02297997Early Phase 1
Preventive Effects of Cetylpyridinium Chloride on SarcopeniaStudy
NCT02788786Phase 2
Feasibility and Acceptability of Use of Daily Oral Rinse in Pregnant Women in Rural Nepal
NCT00729599Phase 3
Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.
NCT00687037Phase 3
Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5